Pre-Treatment of platinum resistant ovarian cancer cells with an MMP-9/MMP-2 inhibitor prior to cisplatin enhances cytotoxicity as determined by high content screening.
Laios A, Mohamed BM, Kelly L, Flavin R, Finn S, McEvoy L, Gallagher M, Martin C, Sheils O, Ring M, Davies A, Lawson M, Gleeson N, D'Arcy T, d'Adhemar C, Norris L, Langhe R, Saadeh FA, O'Leary JJ, O'Toole SA.
Laios A, et al. Among authors: mohamed bm.
Int J Mol Sci. 2013 Jan 22;14(1):2085-103. doi: 10.3390/ijms14012085.
Int J Mol Sci. 2013.
PMID: 23340649
Free PMC article.